BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 31776770)

  • 1. Mast cell activation in the context of elevated basal serum tryptase: genetics and presentations.
    Khoury P; Lyons JJ
    Curr Allergy Asthma Rep; 2019 Nov; 19(12):55. PubMed ID: 31776770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated Basal Serum Tryptase: Disease Distribution and Variability in a Regional Health System.
    Waters AM; Park HJ; Weskamp AL; Mateja A; Kachur ME; Lyons JJ; Rosen BJ; Boggs NA
    J Allergy Clin Immunol Pract; 2022 Sep; 10(9):2424-2435.e5. PubMed ID: 35032694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inherited and acquired determinants of serum tryptase levels in humans.
    Lyons JJ
    Ann Allergy Asthma Immunol; 2021 Oct; 127(4):420-426. PubMed ID: 34175497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hymenoptera venom-induced anaphylaxis and hereditary alpha-tryptasemia.
    O'Connell MP; Lyons JJ
    Curr Opin Allergy Clin Immunol; 2020 Oct; 20(5):431-437. PubMed ID: 32769710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Routine KIT p.D816V screening identifies clonal mast cell disease in patients with Hymenoptera allergy regularly missed using baseline tryptase levels alone.
    Šelb J; Rijavec M; Eržen R; Zidarn M; Kopač P; Škerget M; Bajrović N; Luzar AD; Park YH; Liu Y; Šerbec VČ; Zver S; Košnik M; Lyons JJ; Korošec P
    J Allergy Clin Immunol; 2021 Aug; 148(2):621-626.e7. PubMed ID: 33753098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hereditary Alpha-Tryptasemia: a Commonly Inherited Modifier of Anaphylaxis.
    Wu R; Lyons JJ
    Curr Allergy Asthma Rep; 2021 May; 21(5):33. PubMed ID: 33970354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heritable risk for severe anaphylaxis associated with increased α-tryptase-encoding germline copy number at TPSAB1.
    Lyons JJ; Chovanec J; O'Connell MP; Liu Y; Šelb J; Zanotti R; Bai Y; Kim J; Le QT; DiMaggio T; Schwartz LB; Komarow HD; Rijavec M; Carter MC; Milner JD; Bonadonna P; Metcalfe DD; Korošec P
    J Allergy Clin Immunol; 2021 Feb; 147(2):622-632. PubMed ID: 32717252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resolving the genetics of human tryptases: implications for health, disease, and clinical use as a biomarker.
    O'Connell MP; Lyons JJ
    Curr Opin Allergy Clin Immunol; 2022 Apr; 22(2):143-152. PubMed ID: 35197435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defining baseline variability of serum tryptase levels improves accuracy in identifying anaphylaxis.
    Mateja A; Wang Q; Chovanec J; Kim J; Wilson KJ; Schwartz LB; Glover SC; Carter MC; Metcalfe DD; Brittain E; Lyons JJ
    J Allergy Clin Immunol; 2022 Mar; 149(3):1010-1017.e10. PubMed ID: 34425177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clonal mast cell disorders and hereditary α-tryptasemia as risk factors for anaphylaxis.
    Kačar M; Rijavec M; Šelb J; Korošec P
    Clin Exp Allergy; 2023 Apr; 53(4):392-404. PubMed ID: 36654513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic Regulation of Tryptase Production and Clinical Impact: Hereditary Alpha Tryptasemia, Mastocytosis and Beyond.
    Sprinzl B; Greiner G; Uyanik G; Arock M; Haferlach T; Sperr WR; Valent P; Hoermann G
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33671092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetically defined individual reference ranges for tryptase limit unnecessary procedures and unmask myeloid neoplasms.
    Chovanec J; Tunc I; Hughes J; Halstead J; Mateja A; Liu Y; O'Connell MP; Kim J; Park YH; Wang Q; Le Q; Pirooznia M; Trivedi NN; Bai Y; Yin Y; Hsu AP; McElwee J; Lassiter S; Nelson C; Bandoh J; DiMaggio T; Šelb J; Rijavec M; Carter MC; Komarow HD; Sabato V; Steinberg J; Hafer KM; Feuille E; Hourigan CS; Lack J; Khoury P; Maric I; Zanotti R; Bonadonna P; Schwartz LB; Milner JD; Glover SC; Ebo DG; Korošec P; Caughey GH; Brittain EH; Busby B; Metcalfe DD; Lyons JJ
    Blood Adv; 2023 May; 7(9):1796-1810. PubMed ID: 36170795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incorporating Tryptase Genotyping Into the Workup and Diagnosis of Mast Cell Diseases and Reactions.
    Lyons JJ; Greiner G; Hoermann G; Metcalfe DD
    J Allergy Clin Immunol Pract; 2022 Aug; 10(8):1964-1973. PubMed ID: 35597543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hereditary alpha-tryptasemia.
    Bonadonna P; Nalin F; Olivieri F
    Curr Opin Allergy Clin Immunol; 2022 Oct; 22(5):277-282. PubMed ID: 35942852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha-Tryptase as a Risk-Modifying Factor for Mast Cell-Mediated Reactions.
    Shin H; Lyons JJ
    Curr Allergy Asthma Rep; 2024 Apr; 24(4):199-209. PubMed ID: 38460022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical relevance of inherited genetic differences in human tryptases: Hereditary alpha-tryptasemia and beyond.
    Glover SC; Carter MC; Korošec P; Bonadonna P; Schwartz LB; Milner JD; Caughey GH; Metcalfe DD; Lyons JJ
    Ann Allergy Asthma Immunol; 2021 Dec; 127(6):638-647. PubMed ID: 34400315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hereditary α tryptasemia is a valid genetic biomarker for severe mediator-related symptoms in mastocytosis.
    Greiner G; Sprinzl B; Górska A; Ratzinger F; Gurbisz M; Witzeneder N; Schmetterer KG; Gisslinger B; Uyanik G; Hadzijusufovic E; Esterbauer H; Gleixner KV; Krauth MT; Pfeilstöcker M; Keil F; Gisslinger H; Nedoszytko B; Niedoszytko M; Sperr WR; Valent P; Hoermann G
    Blood; 2021 Jan; 137(2):238-247. PubMed ID: 32777817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical characteristics and risk profile of patients with elevated baseline serum tryptase.
    Fellinger C; Hemmer W; Wöhrl S; Sesztak-Greinecker G; Jarisch R; Wantke F
    Allergol Immunopathol (Madr); 2014; 42(6):544-52. PubMed ID: 25224360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Genetic Basis and Clinical Impact of Hereditary Alpha-Tryptasemia.
    Luskin KT; White AA; Lyons JJ
    J Allergy Clin Immunol Pract; 2021 Jun; 9(6):2235-2242. PubMed ID: 33744473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patients with mast cell activation symptoms and elevated baseline serum tryptase level have unique bone marrow morphology.
    Giannetti MP; Akin C; Hufdhi R; Hamilton MJ; Weller E; van Anrooij B; Lyons JJ; Hornick JL; Pinkus G; Castells M; Pozdnyakova O
    J Allergy Clin Immunol; 2021 Apr; 147(4):1497-1501.e1. PubMed ID: 33248113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.